YOLFTbeta
Pila Pharma AB

Pila Pharma AB

PILA · ST · Healthcare / Biotechnology

1.67SEK-0.03 (-1.76%)

Price History

Full chart

Market Stats

Previous Close1.70
Open1.70
Day Range1.67 – 1.70
52-Week Range1.02 – 2.50
Volume15.58K
Market Cap79.49M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.33
Dividend Yield0.00%
Beta-0.30
50-Day Avg1.59
200-Day Avg1.55

About

Pila Pharma AB (publ) operates as a clinical stage biotech company in Sweden. The company develops XEN-D0501, a TRPV1 antagonist in Phase 2a trial for obesity, diabetes, and heart failure; Phase 1 trial for erythromelalgia, inflammation pain, and rare diseases; and preclinical trial for abdominal aorta aneurism and cardiovascular diseases. Pila Pharma AB (publ) was incorporated in 2014 and is headquartered in Malmö, Sweden.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Gustav Hanghoj Gram
  • Employees0
  • HeadquartersNorra Vallgatan 72, Malmö, Sweden, 211 22, Sweden
  • Websitehttps://pilapharma.com

Leadership

  • Ms. Dorte Xenia GramFounder, Chairman & Chief Scientific Officer · b. 1969
  • Mr. Gustav Hanghoj GramChief Executive Officer · b. 1993
  • Mr. Hampus DarrellChief Financial Officer · b. 1973
  • Mr. Miguel LecumberriHead of Compliance & Legal Affairs
  • Mr. Masoud AlaviHead of Corporate Visual Communication
  • Mr. Andy MakinHead of Toxicology
  • Ms. Maura McArdleHead of BD & Quay Pharma
  • Mr. Mike FrodshamCTO of Quay Pharma
  • Ms. Alison FosterHead of Pre-Clinical - Quay Pharma
  • Mr. Simon HamiltonHead of Global Business Development - Almac

Financials

Income Statement

Currency: SEK2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue---0346.44K0719.23K1.88M1.46M775.00K1.13M
Growth (%)------100.00%-+161.49%-22.21%-47.03%+45.42%
Cost of Revenue660.56K379.88K7.53K2.93M2.43M492.39K38.29K10.77M7.86M8.90M7.94M
Gross Profit-660.56K-379.88K-7.53K-2.93M-2.08M-492.39K680.94K1.88M1.46M-8.12M-6.82M
Gross Margin-----600.96%-94.68%100.00%100.00%-1048.28%-604.88%
Operating Expense239.29K1.09M4.79M2.02M2.64M2.89M9.94M10.77M7.86M-15.14K1.08M
Operating Income-899.85K-1.47M-4.79M-4.95M-4.72M-3.38M-9.26M-8.89M-6.39M-8.11M-7.89M
Operating Margin-----1361.90%--1287.57%-472.69%-436.99%-1046.32%-700.44%
EBITDA-416-17.17K-4.73M-4.93M-8.65M-3.36M-17.16M-26.76M-8.81M-10.11M-15.92M
EBITDA Margin-----2496.52%--2385.41%-1422.87%-602.35%-1304.67%-1412.73%
Net Income-900.27K-1.49M-4.77M-5.60M-8.67M-10.58M-17.21M-26.78M-9.93M-11.24M-16.86M
Net Income Margin-----2502.34%--2392.46%-1423.74%-678.73%-1450.45%-1496.27%
Interest Expense--094488220230.54K65840.09K53.00K219.00K
Interest Expense % of Total Revenue----0.25%-4.25%0.03%2.74%6.84%19.43%

Balance Sheet

Currency: SEK2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets387.78K1.29M7.52M7.32M7.94M5.37M31.81M10.89M8.46M6.22M16.22M
Total Liabilities245.91K644.76K561.37K821.98K484.68K1.95M1.51M1.36M1.79M963.00K1.43M
Total Equity141.87K645.51K6.96M6.49M7.46M3.42M30.30M9.53M6.66M5.26M14.78M
Cash325.25K1.07M6.76M3.42M4.07M1.91M28.21M7.24M5.95M4.89M15.90M
Total Debt50.00K440.00K80.00K--500.00K--773.08K--
Net Debt-275.25K-634.32K-6.68M-3.42M-4.07M-1.41M-28.21M-7.24M-5.95M-4.89M-15.90M

Cash Flow

Currency: SEK2015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow----4.56M-5.02M-2.00M-9.36M-9.09M-4.85M-7.82M-9.19M
Investing Cash Flow----3.18M-15.07K------
Financing Cash Flow---4.41M5.68M-158.07K35.67M-11.88M3.56M6.76M20.19M
Capital Expenditure0003.18M15.07K000040
Free Cash Flow----7.75M-5.04M-2.00M-9.36M-9.09M-4.85M-7.82M-9.19M
FCF to OCF---169.73%100.30%100.00%100.00%100.00%100.00%100.00%100.00%

Earnings

Report DateOct 26, 2021Feb 18, 2022Apr 26, 2022Aug 26, 2022Oct 26, 2022Dec 31, 2022Apr 26, 2023Aug 23, 2023Oct 25, 2023Feb 28, 2024
EPS Estimate----------
EPS Actual-0.38-0.33-0.63-0.39-0.36-0.21-0.22-0.17-0.08-0.06
Surprise----------
TimingPre-marketPre-marketAfter-hoursPre-marketPre-market-After-hoursAfter-hoursAfter-hoursAfter-hours

Key Statistics & Ratios

Market Cap79.49M
Enterprise Value71.89M
Trailing P/E0.00
Forward P/E0.00
Price / Sales288.27
Price / Book4.66
EPS-0.33
Book Value0.353
Revenue (TTM)275.74K
Gross Profit (TTM)-5.95M
EBITDA-6.71M
Profit Margin0.00%
Operating Margin-2825.75%
Return on Equity-194.16%
Return on Assets-47.89%
Shares Outstanding45.68M
Shares Float29.95M
Beta-0.30
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jun 26, 20253194:2849
  • Oct 31, 20221025:1001